z-logo
Premium
American Cancer Society signals transition in cervical cancer screening from cytology to HPV tests
Author(s) -
Davey Diane Davis
Publication year - 2021
Publication title -
cancer cytopathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.29
H-Index - 57
eISSN - 1934-6638
pISSN - 1934-662X
DOI - 10.1002/cncy.22429
Subject(s) - medicine , cytology , cervical cancer , human papillomavirus , cancer , cervical cancer screening , cancer detection , gynecology , cancer screening , obstetrics , oncology , pathology
The 2020 American Cancer Society cervical cancer screening guidelines call for a shift to primary human papillomavirus testing every 5 years, with cotesting and cytology alone acceptable where primary testing platforms are not available. Initiation of screening is recommended at the age of 25 years instead of 21 years.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here